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Abstract
Purpose:We report a case with iris heterochromia misdiagnosed as Fuchs’ uveitis which
finally turned out to be a unilateral zoster uveitis in an HIV-positive patient.
Case Report: A 45-year old patient was seen for a recurrent right anterior uveitis
treated with prednisolone 1% drops BID. The iris of the right eye was hypochromic and
atrophic and several small granulomatous keratic precipitates (KPs) were present. After
discontinuation of corticosteroid drops, severe uveitis developed with mutton-fat KPs,
and laser flare photometry (LFP) increased from 20 to 50.3 ph/ms. He had presentedwith
right zoster ophthalmicus two years earlier and HIV-serology revealed to be positive.
Conclusion: Iris heterochromia is not a good disease-defining criterion for Fuch’s
uveitis even when typical KPs are present and can lead to misdiagnosis. More reliable
criteria including stellate KPs, low LFP values, absence of synechiae, vitreitis, and disc
hyperfluorescence, all absent in this case, should be sought to confirm or exclude the
diagnosis.
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INTRODUCTION
Fuchs’ uveitis (FU) is often underdiagnosed
because too much importance is given to iris
heterochromia at the expense of other more
disease-defining clinical signs. The disease was
described by Ernst Fuchs at the beginning of
the last century in Vienna, Austria, inhabited by
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a Caucasian population.[1, 2] Iris heterochromia had
a prominent part in the definition of the disease
in his publications[1] and his textbook, which was
translated into more than 10 languages including
countries with all brown iris populations. In these
countries such as Japan[3] and many others,
FU was underdiagnosed because clinicians
were (1) looking in vain for heterochromia that
does not exist in brown irises and (2) ignored
the clinical sign of vitreitis present in close to
100% of cases.[4] Therefore, strong and universal
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disease-defining signs have to be used to confirm
or exclude FU. These criteria, all present in
>90% of non-operated cases, include vitritis,[4]
small stellate keratic precipitates (KPs), low
aqueous flare values measured by laser flare
photometry (LFP, ≤ 20 ph/ms),[5] absence of
posterior synechiae, difference of texture of irises
between the two eyes, absence of cystoid macular
oedema, and hyperfluorescent disc on fluorescein
angiography (FA).[6] Here, we present a case
where iris heterochromia led to falsely diagnosed
FU in a case of recurrent zoster uveitis in an
immunocompromised patient.
CASE REPORT
A 45-year old teacher was referred to our uveitis
clinic by his treating eye doctor for a recurrent right
granulomatous uveitis. History revealed that he
had gone through right herpes zoster ophthalmicus
(HZ.O) two years prior.
At presentation, the patient was under the
treatment of 1% prednisolone acetate eye drop,
twice daily. Uncorrected visual acuity ODS was 1.0
on the Snellen chart.
On the right corneal endothelium, there
were rare small randomly distributed stellate
KPs compatible with FU [Figure 1]. The anterior
chamber was uninflamed on slit-lamp examination
but LFP measured a sub-clinical inflammation
of 20.2 ph/ms (normal = 3–6 ph/ms). Intraocular
pressure was 12 mmHg OD and 14 mmHg OS.
An iris heterochromia was noted with a lighter
iris on the right and an altered hyalinized iris
surface [Figure 2]. There was no sectorial iris
atrophy. There were rare cells in the anterior
vitreous OD. Fundus examination as well as retinal
and choroidal optical tomography (OCT) were
normal. We made the diagnosis of FU based on
typical KPs and heterochromia and stopped the
corticosteroid drops. FA performed the following
day did not show the disc hyperfluorescence
usually seen in FU [Figure 3] nor the limited
peripheral vascular leakage often present in
FU. Ten days later, the patient returned with a
severe granulomatous uveitis with numerous
mutton-fat KPs [Figure 4] and increase of LFP
values to 51.4 ph/ms associated with posterior
synechiae [Figure 4]. The diagnosis was revised
to recurrent zoster uveitis and the patient was
treated with valacyclovir 1000 mg TID and
1% prednisolone acetate drops 5× per day.
The uveitis responded well to treatment with
resolution of the mutton-fat KPs and reduction
of LFP values to 20.7 ph/ms. However, at each
tapering attempt, the uveitis recurred. As we
suspected an immune deficiency to varicella-
zoster virus or a more general immunodepression,
we asked the patient to give us his consent
to search for HIV infection. HIV serology was
positive, and the CD4 lymphocyte count was
reduced to 332 cells/mm3. After the two
attempts to taper the treatment, we decided
to leave the patient under combined systemic
antiviral treatment and corticosteroid drops and
to wait until the CD4 count would be back
to normal after the initiation of antiretroviral
therapy.
DISCUSSION
Iris heterochromia is still too strongly associated
with FU while better disease-defining criteria
have been put forward.[6, 7] Outside FU, viral-
related iris heterochromia has been described in
association with cytomegalovirus[8] and with Ebola
virus.[9] In a large series of viral anterior uveitis
cases with etiologic agents proven by aqueous
PCR, iris heterochromia was never detected in
varicella-zoster uveitis.[10] Although a thorough
literature search remained negative, it is not
impossible “a priori” that zoster uveitis can produce
heterochromia, which was the case in our patient.
The differential diagnosis of FU and herpetic
anterior uveitis can be easier when large, mutton
fat-like KP’s are present, which can exclude FU.
In the early stages of herpetic anterior uveitis,
mutton-fat KP’s can very rarely be absent, confusing
the ophthalmologist. They can also be absent
after a period of local corticosteroid treatment,
as it happened in our case, which can lead
to misdiagnosis. Discontinuing the corticosteroid
drops and re-examining our patient after 10 days
revealed abundant mutton-fat KPs, increase of flare
and posterior synechiae, features incompatible
with FU.
Once FU was excluded and after two failed
attempts to taper antiviral and corticosteroid
treatment, we decided to search for an immune
deficiency specifically to varicella-zoster virus
(VZV) or a more global immunodeficiency. It is
known that herpes zoster in patients under the age
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Figure 1. Sparse micro-granulomatous KPs, seen in magnification (insert) at presentation under the treatment of 1% prednisolone
drops BID.
Figure 2. Heterochromia with a lighter-colored iris on the right (top). Bottom two pictures show a right discolored iris with an
altered hyalinized iris texture (left picture).
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Figure 3. Absence of disc hyperfluorescence in the right affected eye on FA in the presented case (top angiographic frames). In
comparison, bottom two frames show the typical disc hyperfluorescence seen in Fuchs’ uveitis.
Figure 4.Massivemutton-fat KPs deposition on the endothelium in the right eye (left picture) after discontinuation of corticosteroid
drops and posterior ruptured synechiae (right picture), incompatible with Fuchs’ uveitis.
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of 50 is associated with HIV infection. In patients
with a CD4 count from 200 to 349 cells/mm3 which
was the case for our patient, herpes zoster is listed
as the third most frequent clinical condition (12%)
of missed opportunity for earlier diagnosis of HIV
infection.[11] Another trial showed that herpes zoster
was a clinical event in late presenters with HIV
infection indicating missed opportunities for earlier
diagnosis in 19.8% of the cases.[12]
On the other hand, it was shown in a series
of 89/581 (14.3%) HIV-positive uveitis patients that
the first cause of anterior uveitis was due to VZV
amounting to 43%.[13]
VZV was shown to persist for much longer in
tissues of HIV-positive patients and even that there
was a rebound inflammation when anti-retroviral
treatment was started.[14, 15] Therefore, we left the
patient under dual systemic antiviral and topical
corticosteroid therapy after introduction of anti-
retroviral therapy and CD4 count recovery.
The ophthalmologist, in presence of VZV
pathology in patients under the age of 50, should
function as a whistle blower in order not to miss an
early diagnostic opportunity for HIV infection.
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